Richard Pzena’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7M Buy
1,205,587
+96,654
+9% +$1.82M 0.08% 116
2026
Q1
$19.4M Sell
1,108,933
-25,496
-2% -$506K 0.06% 119
2025
Q4
$22.3M Sell
1,134,429
-78,159
-6% -$1.62M 0.07% 115
2025
Q3
$33.4M Buy
1,212,588
+14,328
+1% +$441K 0.11% 105
2025
Q2
$36.6M Buy
1,198,260
+103,074
+9% +$2.93M 0.12% 101
2025
Q1
$29.5M Buy
1,095,186
+8,110
+0.7% +$257K 0.1% 106
2024
Q4
$39M Buy
1,087,076
+37,466
+4% +$1.4M 0.13% 88
2024
Q3
$39.8M Buy
1,049,610
+72,977
+7% +$3M 0.13% 91
2024
Q2
$44.2M Buy
976,633
+191,289
+24% +$8.8M 0.16% 82
2024
Q1
$38.1M Buy
785,344
+23,729
+3% +$1.16M 0.13% 96
2023
Q4
$40.8M Sell
761,615
-25,824
-3% -$1.31M 0.15% 95
2023
Q3
$46.2M Sell
787,439
-2,606
-0.3% -$163K 0.2% 86
2023
Q2
$49.8M Sell
790,045
-28,339
-3% -$1.8M 0.21% 80
2023
Q1
$51.5M Buy
818,384
+101,503
+14% +$6.06M 0.22% 79
2022
Q4
$38.1M Sell
716,881
-4,654
-0.6% -$252K 0.17% 98
2022
Q3
$40.4M Sell
721,535
-4,116
-0.6% -$272K 0.2% 83
2022
Q2
$52.5M Sell
725,651
-8,288
-1% -$617K 0.24% 75
2022
Q1
$58.3M Buy
733,939
+288,307
+65% +$26M 0.22% 79
2021
Q4
$45.1M Buy
445,632
+349,924
+366% +$34.9M 0.17% 93
2021
Q3
$8.82M Buy
+95,708
New +$9.21M 0.03% 118

Other funds holding USNA

Richard Pzena's USNA Position: Q2 2026 in Review

Richard Pzena increased its Usana Health Sciences (USNA) stake by 8.7% in Q2 2026, buying an estimated $1.82M and bringing the position to 1,205,587 shares worth $25.7M. The position accounts for 0.08% of the portfolio, ranked #116.

Richard Pzena first reported a position in USNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $58.3M in Q1 2022. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Richard Pzena held 1,205,587 shares of Usana Health Sciences worth $25.7M as of Q2 2026.
  • Richard Pzena bought 96,654 Usana Health Sciences shares in Q2 2026, an estimated $1.82M.
  • Usana Health Sciences made up 0.08% of Richard Pzena's portfolio in Q2 2026, its #116 holding.
  • Richard Pzena first reported a position in Usana Health Sciences in Q3 2021 and has held it in 20 quarters since.
  • Richard Pzena's Usana Health Sciences position peaked at $58.3M in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Pzena Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.